'The window of opportunity is closing'-advocating urgency and unity

The paper investigates how the metaphor of a 'closing window of opportunity' is mobilised in Finnish biomedicine to advocate research- and innovation-friendly policies. Framed as a generative, persuasive metaphor, it emphasizes temporal scarcity and urgency to act, aligning with broader discourses on expectations and socio-technical imaginaries. The research question asks how this metaphor frames policy and regulatory change through lenses of urgency and national unity, and with what consequences for debate, policy-making, and governance in biomedicine and health data. The authors argue that such urgency may crowd out deliberation on values, risks, and responsibilities, potentially fostering hastily prepared, reflex regulatory action.

The study draws on work on metaphors as framing and persuasive devices in science communication and policy (e.g., Schön; Stone; Nelkin; Nerlich; Hellsten; Koteyko). Generative metaphors shape problem definitions, solutions, and implied narratives, making some aspects salient while backgrounding others. It situates the analysis within the sociology of expectations (Borup; Brown & Michael; van Lente), including the co-articulation of positive and negative expectations (Tutton) and 'early warnings' (Nerlich & Halliday). It engages with socio-technical imaginaries (Jasanoff & Kim), and temporal politics in innovation policy—commodified time, near-term prioritization, and the 'temporal reflex' of political expediency (Brown & Beynon-Jones). Prior studies note how economic and techno-scientific promises create constant urgency, positioning nations in global competition and aligning policymaking with enabling environments for rapid innovation.

Empirical case: Finnish biomedicine and health data policy (biobanks, genomic data, health registers) and their framing as national assets. Context includes key developments: the Biobank Act (2012) leading to the establishment of 11 biobanks; initiatives toward a national genome centre; and the law on secondary use of social and health data establishing a centralized licensing authority (Findata) and services such as Fingenious. Data: (1) Fieldnotes from participation in dozens of Finnish, Nordic, and international expert events and stakeholder seminars from the 2010s concerning biomedicine, biobanks, genomics, and health data. (2) Publicly available digital materials (2012–2019 primarily, with additional materials from 2005–2011): official reports/strategies, media articles, presentation slides, and stakeholder web pages, identified via searches for 'window of opportunity', 'closing window', and 'time window' in Finnish and English in relation to Finland, genomics, biobanks, and health data. Finnish statements were translated into English by the authors. Analytic approach: Metaphors are treated as framing devices that shape issue understanding, problem definitions, and causal interpretations. Quotations and references were first organized contextually (by source and venue) and temporally, then thematically analysed using both data-driven and literature-informed coding, drawing on prior experience in the domain while seeking anomalous insights. The analysis identified a consistent framing across stakeholders anchored to two elements: (1) international competition (urgent exploitation of existing strengths/infrastructures), and (2) national unity (centralized infrastructures and one-stop shops).

• The 'closing window of opportunity' metaphor is widely and consistently used by Finnish stakeholders (researchers, biobank managers, industry, funding bodies, ministries) to frame an urgent, time-limited need to act to create an enabling environment for biomedical R&D and data-driven medicine. • Two core framing elements: – International competition: Finland is depicted as having distinctive assets (population registers, biobanks, digital records, a unique/willing population, personal ID number, enabling legislation), a 'head start', and a narrow time horizon ('a few years', 'a couple of years', 'the next five years') to capitalize before competitors (e.g., Estonia, UK, Germany; projects such as UK Biobank) catch up. Retro-collections and specific population genetic features are highlighted as time-sensitive opportunities. – National unity: Success is tied to acting as a single, coordinated entity with centralized, standardized access points (e.g., Fingenious, Findata) and harmonized practices—'speaking with one voice'. The metaphor supports calls for restructuring (e.g., a biobank co-op, 2017) and building one-stop shops to remain attractive to global partners. • The urgency is presented as constant and elastic: while the window is said to be closing imminently and repeatedly (since at least the mid-2000s), it never fully closes; the timeframe shifts to fit evolving objectives and infrastructures. • The metaphor co-articulates pessimistic expectations (threat of losing competitiveness and investment) with optimistic promises (economic growth, scientific leadership), effectively coordinating action and resources. • Policy and regulatory implications: The metaphor legitimizes swift legislative and infrastructural changes to maintain competitiveness, potentially leading to 'reflex regulation' driven by perceived short-term needs. • Silencing of critique: Emphasis on urgency and unity sidelines broader ethical, social, and political debates (e.g., sustainability, responsibility, accountability, privacy, consent, benefit sharing). • Illustrative contextual data: 11 biobanks established after the Biobank Act (2012); major initiatives (Findata, Fingenious); dataset spans 2005–2019, covering periods of strategy and regulatory development.

The 'closing window' operates as a generative, persuasive metaphor that makes the goals of innovation and competitiveness appear obvious and urgent, coordinating stakeholders toward shared action while backgrounding deliberation on risks and values. As a negative expectation paired with a ready solution (fast, unified action), it complements optimistic visions in biomedicine and helps mobilize resources and policy changes. However, the perpetual state of urgency risks fostering 'reflex regulation'—hasty, reactive policy that undermines debate, evaluation, and transparency around emerging technologies. The metaphor’s flexible temporality sustains pressure without a definitive endpoint, enabling continued policy momentum yet potentially constraining reflective governance and critical public discourse, even as Finland is portrayed as a unified national actor in a global competition.

The study shows how the 'closing window of opportunity' metaphor frames Finnish biomedical R&D and data policy through urgency and national unity, functioning as a generative device that rallies action, resources, and regulatory change to maintain international competitiveness. While effective for mobilization, its persistent urgency risks reflexive, hasty regulation and narrows space for ethical and societal debate. The metaphor remains adaptable over time—continually 'closing'—thereby repeatedly justifying swift action and centralized coordination (e.g., one-stop data access). The authors contribute to scholarship on metaphors, expectations, and imaginaries by revealing how negative expectations and urgency are co-produced with policy ends in biomedicine, and by raising concerns about the silencing of broader deliberations in the drive for rapid innovation.

The analysis relies on fieldnotes from numerous events and publicly available digital materials rather than full recordings; fieldnotes were not quoted verbatim and served primarily to guide analysis. Publicly available documents and searches may omit non-public or informal communications. The events observed brought together experts from academia, industry, and public sector governance but notably did not include political decision-makers, potentially shaping the discourse captured. The study focuses on Finland and the 2005–2019 period, which may limit generalizability.